TrialClinical and translational science2026

A First-In-Human Randomized Controlled Phase 1 Study Assessing the Safety and Tolerability of Topical TCP-25 Gel in Epidermal Suction Blister Wounds.

Karl Wallblom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.